PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Dopamine and Amitriptyline Interaction

Drug interaction information between Dopamine and Amitriptyline.

Dopamine and Amitriptyline have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Dopamine and Amitriptyline. Major interactions are generally avoided, moderate ones may need monitoring or a dose adjustment, and minor ones are usually low-risk. This page shows the documented mechanism and guidance. Label-documented interactions are not a complete safety review, so always confirm your own medications with a pharmacist or doctor. Educational information, not medical advice.

Drug A

Dopamine

Inotropic / Vasopressor

Drug B

Amitriptyline

Tricyclic Antidepressant (TCA)

How They Interact

Amitriptyline can make your heart and blood vessels more sensitive to dopamine. This can cause your blood pressure to rise higher than it normally would.

What To Do

Your doctor should monitor your blood pressure and heart rate very closely. They may need to use a smaller dose of dopamine.

FDA Label Information

Examples: amitriptyline, desipramine, doxepin, imipramine, nortriptyline.

Frequently Asked Questions

Can I take Dopamine and Amitriptyline together?

This is a minor interaction. Your doctor should monitor your blood pressure and heart rate very closely. They may need to use a smaller dose of dopamine.

How serious is the interaction between Dopamine and Amitriptyline?

This interaction is classified as "minor" severity by the FDA. Minor interactions are unlikely to cause significant problems but should still be mentioned to your healthcare provider.

Why do Dopamine and Amitriptyline interact?

Amitriptyline can make your heart and blood vessels more sensitive to dopamine. This can cause your blood pressure to rise higher than it normally would.

Understanding the Dopamine and Amitriptyline Interaction

FDA-approved prescribing information for these two drugs flags their combination as a minor-severity interaction. Dopamine belongs to the Inotropic / Vasopressor class and Amitriptyline belongs to the Tricyclic Antidepressant (TCA) class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: Amitriptyline can make your heart and blood vessels more sensitive to dopamine. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.

Context around a specific patient determines real-world impact. Dopamine has 28 total documented interactions on file in this dataset, and Amitriptyline has 21. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Your doctor should monitor your blood pressure and heart rate very closely. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.

An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Dopamine or Amitriptyline based on a web page, speak with your prescriber or pharmacist before making any change.

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. Always consult your healthcare provider about drug interactions.